MRI, PET and CT scans allow for accurate interpretation which aids is surgical planning and radiation planning.
Our surgeons are not only experienced in the removal of sarcomas, but also in how best to reconstruct the tissue or skeletal defect, maximizing the patient’s post-operative function. Procedures include biopsy of primary tumors, removal of primary tumors, limb-sparing surgery and surgical treatment of metastatic disease.
Our experts guide the selection of appropriate post-surgical therapy and manage systemic therapy options specific to your sarcoma subtype including bone, soft tissue sarcomas and non-gastrointestinal stromal tumors.
Our pathologists take advantage of advancements in cancer genetics and technology using genetic markers to aid in diagnosis and prognosis.
Personalized tumor staging, chemotherapy and radiation plans are developed by a multidisciplinary team experienced in sarcoma.
Clinical trials for cutting-edge sarcoma therapies are showing promising results for patients and helping to further our understanding of this disease. Dedicated sarcoma trials are available including trials specific for leiomyosarcoma, liposarcoma, GIST, angiosarcoma and bone tumors such as chondrosarcoma.
Along with state-of-the-art treatments, Hollings assists patients in dealing with the financial, physical and emotional aspects of having cancer.
Author and sarcoma advocate, Thom Schmenk celebrates five years cancer-free.Patient Story
As an NCI-Designated Cancer Center, Hollings is part of a national network of clinical trials, with access to hundreds of trials across the United States.